UBS Group restated their neutral rating on shares of GIVAUDAN SA/ADR (OTCMKTS:GVDNY) in a research report sent to investors on Thursday morning, Borsen Zeitung reports.
GVDNY has been the subject of a number of other reports. Barclays reaffirmed a hold rating and issued a $52.00 target price on shares of Biohaven Pharmaceutical in a research note on Tuesday, March 19th. Goldman Sachs Group downgraded shares of TerraForm Power from a neutral rating to a sell rating and set a $12.00 target price for the company. in a research note on Tuesday, April 9th. They noted that the move was a valuation call. Deutsche Bank raised shares of SUN ART RETAIL/ADR from a hold rating to a buy rating in a research note on Wednesday, July 3rd. Sanford C. Bernstein set a €77.00 ($89.53) target price on shares of Symrise and gave the stock a neutral rating in a research note on Friday, May 24th. Finally, Kepler Capital Markets set a €25.40 ($29.53) target price on shares of Deutsche Lufthansa and gave the stock a buy rating in a research note on Wednesday, April 10th. Five analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. GIVAUDAN SA/ADR currently has a consensus rating of Hold.
Shares of OTCMKTS GVDNY opened at $55.71 on Thursday. GIVAUDAN SA/ADR has a 1-year low of $44.90 and a 1-year high of $58.00. The business has a 50-day moving average of $55.06.
Givaudan SA, together with its subsidiaries, manufactures and sells fragrance and flavor products to the food, beverage, consumer goods, and fragrance and cosmetics industries worldwide. The company operates through two divisions, Fragrance and Flavour. The Fragrance division provides fragrance ingredients and active beauty products; fine fragrances, such as signature fragrances and line extensions; and fragrances for use in fabric and personal care, hair and skin care, household and air care, and oral care products.
Featured Article: Depreciation
Receive News & Ratings for GIVAUDAN SA/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GIVAUDAN SA/ADR and related companies with MarketBeat.com's FREE daily email newsletter.